184 related articles for article (PubMed ID: 11111056)
21. Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation.
Errington F; Willmore E; Tilby MJ; Li L; Li G; Li W; Baguley BC; Austin CA
Mol Pharmacol; 1999 Dec; 56(6):1309-16. PubMed ID: 10570059
[TBL] [Abstract][Full Text] [Related]
22. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
Sakaguchi A; Kikuchi A
J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
[TBL] [Abstract][Full Text] [Related]
23. Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
Dingemans AC; van Ark-Otte J; Span S; Scagliotti GV; van der Valk P; Postmus PE; Giaccone G
Lung Cancer; 2001 May; 32(2):117-28. PubMed ID: 11325482
[TBL] [Abstract][Full Text] [Related]
24. ATF is important to late S phase-dependent regulation of DNA topoisomerase IIalpha gene expression in HeLa cells.
Son MY; Kim TJ; Kweon KI; Park JI; Park C; Lee YC; No Z; Ahn JW; Yoon WH; Park SK; Lim K; Hwang BD
Cancer Lett; 2002 Oct; 184(1):81-8. PubMed ID: 12104051
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle-coupled variation in topoisomerase IIalpha mRNA is regulated by the 3'-untranslated region. Possible role of redox-sensitive protein binding in mRNA accumulation.
Goswami PC; Sheren J; Albee LD; Parsian A; Sim JE; Ridnour LA; Higashikubo R; Gius D; Hunt CR; Spitz DR
J Biol Chem; 2000 Dec; 275(49):38384-92. PubMed ID: 10986283
[TBL] [Abstract][Full Text] [Related]
26. Ectopic expression of human topoisomerase IIalpha fragments and etoposide resistance in mammalian cells.
Ernst AI; Soltermann A; Sigrist JA; Widmer L; Gasser SM; Stahel RA
Int J Cancer; 2000 Oct; 88(1):99-107. PubMed ID: 10962446
[TBL] [Abstract][Full Text] [Related]
27. Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases.
Austin CA; Sng JH; Patel S; Fisher LM
Biochim Biophys Acta; 1993 Mar; 1172(3):283-91. PubMed ID: 8383537
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of DNA topoisomerase IIalpha and beta in human leukaemia cells by immunoblotting.
Padget K; Pearson AD; Austin CA
Leukemia; 2000 Nov; 14(11):1997-2005. PubMed ID: 11069037
[TBL] [Abstract][Full Text] [Related]
29. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.
Washiro M; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Sugimoto T; Seki N; Miyazaki M
J Cancer Res Clin Oncol; 2008 Jul; 134(7):793-801. PubMed ID: 18204862
[TBL] [Abstract][Full Text] [Related]
31. Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform.
Kanagasabai R; Serdar L; Karmahapatra S; Kientz CA; Ellis J; Ritke MK; Elton TS; Yalowich JC
J Pharmacol Exp Ther; 2017 Jan; 360(1):152-163. PubMed ID: 27974648
[TBL] [Abstract][Full Text] [Related]
32. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning.
Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G
Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456
[TBL] [Abstract][Full Text] [Related]
33. Identification of four alternatively spliced isoforms of chicken casein kinase I alpha that are all expressed in diverse cell types.
Green CL; Bennett GS
Gene; 1998 Aug; 216(1):189-95. PubMed ID: 9766967
[TBL] [Abstract][Full Text] [Related]
34. DNA Topoisomerase IIα contributes to the early steps of adipogenesis in 3T3-L1 cells.
Jacobsen RG; Mazloumi Gavgani F; Mellgren G; Lewis AE
Cell Signal; 2016 Oct; 28(10):1593-603. PubMed ID: 27404349
[TBL] [Abstract][Full Text] [Related]
35. 2-[4-(7-chloro-2-quinoxalinyloxyphenoxy]-propionic acid (XK469), an inhibitor of topoisomerase (Topo) IIbeta, up-regulates Topo IIalpha and enhances Topo IIalpha-mediated cytotoxicity.
Mensah-Osman EJ; Al-Katib AM; Wu HY; Osman NI; Mohammad RM
Mol Cancer Ther; 2002 Dec; 1(14):1321-6. PubMed ID: 12516965
[TBL] [Abstract][Full Text] [Related]
36. DNA topoisomerase IIalpha protein and mRNA expression in intracranial meningiomas.
Kunishio K; Morisaki K; Matsumoto Y; Nagao S
Brain Tumor Pathol; 2000; 17(3):105-10. PubMed ID: 11310917
[TBL] [Abstract][Full Text] [Related]
37. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
[TBL] [Abstract][Full Text] [Related]
38. Characterization and expression of three forms of cDNA encoding chicken platelet-derived growth factor-A chain.
Horiuchi H; Inoue T; Furusawa S; Matsuda H
Gene; 2001 Jul; 272(1-2):181-90. PubMed ID: 11470524
[TBL] [Abstract][Full Text] [Related]
39. Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposide.
Grabowski DR; Holmes KA; Aoyama M; Ye Y; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
Mol Pharmacol; 1999 Dec; 56(6):1340-5. PubMed ID: 10570063
[TBL] [Abstract][Full Text] [Related]
40. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
